Stewart CF - Search Results

1

Effect of fractionated ifosfamide on the pharmacokinetics of irinotecan in pediatric patients with osteosarcoma.

Crews KR, Stewart CF, Liu T, Rodriguez-Galindo C, Santana VM, Daw NC. Crews KR, et al. Among authors: stewart cf. J Pediatr Hematol Oncol. 2004 Nov;26(11):764-7. doi: 10.1097/00043426-200411000-00016. J Pediatr Hematol Oncol. 2004. PMID: 15543015 Clinical Trial.

2

Clinical pharmacodynamics of continuous infusion topotecan in children: systemic exposure predicts hematologic toxicity.

Stewart CF, Baker SD, Heideman RL, Jones D, Crom WR, Pratt CB. Stewart CF, et al. J Clin Oncol. 1994 Sep;12(9):1946-54. doi: 10.1200/JCO.1994.12.9.1946. J Clin Oncol. 1994. PMID: 8083716 Clinical Trial.

3

Phase I study of topotecan for pediatric patients with malignant solid tumors.

Pratt CB, Stewart C, Santana VM, Bowman L, Furman W, Ochs J, Marina N, Kuttesch JF, Heideman R, Sandlund JT, et al. Pratt CB, et al. J Clin Oncol. 1994 Mar;12(3):539-43. doi: 10.1200/JCO.1994.12.3.539. J Clin Oncol. 1994. PMID: 8120551 Clinical Trial.

4

Clinical pharmacokinetics and pharmacodynamics of anticancer drugs in children.

Rodman JH, Relling MV, Stewart CF, Synold TW, McLeod H, Kearns C, Stute N, Crom WR, Evans WE. Rodman JH, et al. Among authors: stewart cf. Semin Oncol. 1993 Feb;20(1):18-29. Semin Oncol. 1993. PMID: 8475406 Review.

5

Cerebrospinal fluid pharmacokinetics and penetration of continuous infusion topotecan in children with central nervous system tumors.

Baker SD, Heideman RL, Crom WR, Kuttesch JF, Gajjar A, Stewart CF. Baker SD, et al. Among authors: stewart cf. Cancer Chemother Pharmacol. 1996;37(3):195-202. doi: 10.1007/BF00688317. Cancer Chemother Pharmacol. 1996. PMID: 8529278

6

Phase I trial and pharmacokinetic (PK) and pharmacodynamics (PD) study of topotecan using a five-day course in children with refractory solid tumors: a pediatric oncology group study.

Tubergen DG, Stewart CF, Pratt CB, Zamboni WC, Winick N, Santana VM, Dryer ZA, Kurtzberg J, Bell B, Grier H, Vietti TJ. Tubergen DG, et al. Among authors: stewart cf. J Pediatr Hematol Oncol. 1996 Nov;18(4):352-61. doi: 10.1097/00043426-199611000-00004. J Pediatr Hematol Oncol. 1996. PMID: 8888741 Clinical Trial.

7

Efficacy of oral irinotecan against neuroblastoma xenografts.

Thompson J, Zamboni WC, Cheshire PJ, Richmond L, Luo X, Houghton JA, Stewart CF, Houghton PJ. Thompson J, et al. Among authors: stewart cf. Anticancer Drugs. 1997 Apr;8(4):313-22. doi: 10.1097/00001813-199704000-00002. Anticancer Drugs. 1997. PMID: 9180383

8

Disposition of irinotecan and SN-38 following oral and intravenous irinotecan dosing in mice.

Stewart CF, Zamboni WC, Crom WR, Houghton PJ. Stewart CF, et al. Cancer Chemother Pharmacol. 1997;40(3):259-65. doi: 10.1007/s002800050656. Cancer Chemother Pharmacol. 1997. PMID: 9219511

9

Altered irinotecan and SN-38 disposition after intravenous and oral administration of irinotecan in mice bearing human neuroblastoma xenografts.

Zamboni WC, Houghton PJ, Thompson J, Cheshire PJ, Hanna SK, Richmond LB, Lou X, Stewart CF. Zamboni WC, et al. Among authors: stewart cf. Clin Cancer Res. 1998 Feb;4(2):455-62. Clin Cancer Res. 1998. PMID: 9516936

10

Studies of the efficacy and pharmacology of irinotecan against human colon tumor xenograft models.

Zamboni WC, Stewart CF, Cheshire PJ, Richmond LB, Hanna SK, Luo X, Poquette C, McGovren JP, Houghton JA, Houghton PJ. Zamboni WC, et al. Among authors: stewart cf. Clin Cancer Res. 1998 Mar;4(3):743-53. Clin Cancer Res. 1998. PMID: 9533544

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

322 results

Search Page